Disseminated Intravascular Coagulation - 10 Studies Found
| Completed |
: Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment : Disseminated Intravascular Coagulation : 2012-10-01 : Drug: ART-123 380 U/kg/day or 130 U/kg/day(Subjects with severe renal impairment) for 6 days |
| Withdrawn |
: Study to Look at the Effects of ART-123 on Patients With Sepsis and Disseminated Intravascular Coagulation (DIC) :
: 2010-03-17 :
|
| Completed |
: Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation :
: 2007-06-15 :
|
| Completed |
: An Open-label Study of KW-3357 : Disseminated Intravascular Coagulation (DIC) : 2011-06-27 :
|
| Terminated |
: A Phase 3 Clinical Study of KW-3357 in Patients With DIC : Disseminated Intravascular Coagulation (DIC) : 2011-06-27 : Drug: KW-3357 Intravenous infusion once a day |
| Completed |
: A Clinical Study of KW-3357 in Patients With DIC : Disseminated Intravascular Coagulation (DIC) : 2011-06-27 : Drug: KW-3357 Intravenous infusion once a day |
| Terminated |
: Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis : Disseminated Intravascular Coagulation : 2007-07-23 : Drug: antithrombin alfa (INN name) |
| Not yet recruiting |
: Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation :
: 2015-08-25 :
|
| Terminated |
: Thrombin Generation and Thromboelastography in Non-overt DIC :
: 2006-03-03 |
| Terminated |
: 4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic Shock : Severe Sepsis : 2010-09-29 |